BFSG LLC’s PRA Health Sciences, Inc. PRAH Stock Holding History

BFSG LLC’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,722	Closed	-$207K	–	162
2017 Q3	$207K	Buy	+2,722	New	+$206K	0.09%	137

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFSG LLC's PRAH Position: Q4 2017 in Review

BFSG LLC sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 2,722 shares — an estimated $207K sold.

BFSG LLC first reported a position in PRAH in Q3 2017 and held it in 1 quarter. The position peaked at $207K in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

BFSG LLC reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
BFSG LLC sold 2,722 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $207K.
BFSG LLC first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 1 quarter.
BFSG LLC's PRA Health Sciences, Inc. position peaked at $207K in Q3 2017.
282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on BFSG LLC's 13F filing for Q4 2017, filed 23 Jan 2018.